U.S. Senate committee approves bill that could restrict Chinese biotech
By Thomson ReutersMar 6, 2024 | 10:14 AM
(Reuters) – The U.S. Senate’s homeland security committee voted on Wednesday to move forward a bill that could restrict business with Chinese biotech companies like BGI and WuXi Apptec on national security grounds.
Comments